Patient and physician satisfaction with the Humulin®/Humalog® Pen, a new 3.0-mL prefilled pen device for insulin delivery

Clinical Therapeutics

Volumn 22, Issue 9, 2000, Pages 1049-1067

  Bohannon, Nancy J V ^a   Ohannesian, Joanna P ^b   Burdan, Amy L ^b   Holcombe, John H ^b   Zagar, Anthony ^b  

^a Eli Lilly and Company ^*  (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Diabetes; Insulin pen device; Patient acceptance; Questionnaire

Indexed keywords

HYPERGLYCEMIC AGENT; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DRUG FORMULATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; RELIABILITY; SAFETY; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0033814866     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80084-3     Document Type: Article

References (13)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
3. What the UKPDS really says about cardiovascular disease and glycemic control
4. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents
5. Insulin-pen treatment, quality of life and metabolic control: Retrospective intra-group evaluations
6. Use of a prefilled insulin syringe (Novolin Prefilled(TM)) by patients with diabetes
7. Biologic material in needles and cartridges after insulin injection with a pen in diabetic patients
8. Pen injection and change in metabolic control and quality of life in insulin dependent diabetes mellitus
9. Change in quality of life along with type 1 diabetes
10. Classification and diagnosis of diabetes mellitus and impaired glucose tolerance
11. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe
12. Prefilled insulin pen in newly insulin-treated diabetic patients over 60 years old
13. Safety, efficacy, acceptability of a prefilled insulin pen in diabetic patients over 60 years old